BioMarin, MSD sue Aurobindo over rare disease drug

26-04-2022

Muireann Bolger

BioMarin, MSD sue Aurobindo over rare disease drug

Michael Vi / Shutterstock.com

BioMarin Pharmaceutical and MSD (known as 'Merck & Co' in the US), have sued Aurobindo Pharmaceuticals for patent infringement in a dispute over the drug Kuvan (Sapropterin hydrochloride), used to treat a rare genetic disorder.


BioMarin, MSD, Merck, Aurobindo, Kuvan, ANDA, generic

LSIPR